Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Sallakliniken AB
AB
Active
Org 5591807788
Älvgatan 40, 686 30
Sunne
Other human health activities n.e.c.
·
NACE 8699
Est. 2018 · 7 years old
5 employees
Monitor
Share
Sweden
/
Companies
/
Other human health activities n.e.c.
/
Sallakliniken AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
17M
13M
9M
4M
0M
2021: 8M
8M
2021
2022: 7M (-12% vs 2021)
7M
-12%
2022
2023: 7M (0% vs 2022)
7M
0%
2023
2024: 11M (+57% vs 2023)
11M
+57%
2024
2025: 14M (+27% vs 2024)
14M
+27%
2025
EBITDA
SEK millions
2M
2M
1M
1M
0M
2021: 2M
2M
2021
2022: 1M (-50% vs 2021)
1M
-50%
2022
2023: 1M (0% vs 2022)
1M
0%
2023
2024: 2M (+100% vs 2023)
2M
+100%
2024
2025: 2M (0% vs 2024)
2M
0%
2025
Income statement
SEK thousands
Item
2025
2024
2023
2022
2021
Revenue
14 249
11 469
6 598
6 577
7 602
Staff expenses
−3 791
−3 080
−3 339
−3 610
—
EBITDA
2 154
1 958
524
693
1 500
Depreciation & amort.
−88
−148
−316
−294
−259
EBIT
2 066
1 810
208
400
1 241
Net financials
1
2
1
−2
−2
Profit before tax
2 067
1 813
209
398
1 240
Tax
−431
−380
−39
−89
−270
Net profit
1 636
1 433
170
309
970
Balance sheet
SEK thousands
Item
2025
2024
2023
2022
2021
Total assets
5 291
3 306
1 504
1 784
2 468
Equity
2 511
1 675
493
623
1 114
Long-term debt
—
—
—
—
0
Short-term debt
2 780
1 630
1 011
1 161
1 354
Total debt
2 780
1 630
1 011
1 161
1 354
Financial ratios
5-year trend
EBITDA margin
15,1 %
This company
15,8 %
Market median
This company
Market median
4% below market
2021
2025
Equity ratio
47,5 %
This company
38,2 %
Market median
This company
Market median
24% above market
2021
2025
Return on equity
65,1 %
This company
18,4 %
Market median
This company
Market median
254% above market
2021
2025
Net profit margin
11,5 %
This company
8,1 %
Market median
This company
Market median
42% above market
2021
2025
Asset turnover
2,69×
This company
1,12×
Market median
This company
Market median
140% above market
2021
2025
Debt / equity
1,11×
This company
0,62×
Market median
This company
Market median
79% above market
2021
2025
Annual reports & filings
Annual report 2025
Filed via Bolagsverket / SCB · Period 2024-10-01 – 2025-09-30
View
PDF
Annual report 2024
Filed via Bolagsverket / SCB · Period 2023-10-01 – 2024-09-30
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2022-10-01 – 2023-09-30
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2021-10-01 – 2022-09-30
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2020-10-01 – 2021-09-30
View
PDF
More on Sallakliniken AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
